Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Bonavida

Showing results (161-170 of 192) with videos related to

Pageof 20
Sort By:
Cancer Investigation|February 25, 2009
YY1 Over-expression in human brain gliomas and meningiomas correlates with TGF-beta1, IGF-1 and FGF-2 mRNA levelsStavroula Baritaki, Anthoula M Chatzinikola, Antonios F Vakis, et al.
Cell Cycle (Georgetown, Tex.)|August 9, 2011
Mcl-1 and YY1 inhibition and induction of DR5 by the BH3-mimetic Obatoclax (GX15-070) contribute in the sensitization of B-NHL cells to TRAIL apoptosisMelisa A Martínez-Paniagua, Stavroula Baritaki, Sara Huerta-Yepez, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 10, 2011
An antibody-based multifaceted approach targeting the human transferrin receptor for the treatment of B-cell malignanciesTracy R Daniels, Elizabeth Ortiz-Sánchez, Rosendo Luria-Pérez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2004
Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significanceYoichi Mizutani, Hiroyuki Nakanishi, Kosuke Yamamoto, et al.
British Journal of Haematology|December 5, 2009
The proteasome inhibitor CEP-18770 enhances the anti-myeloma activity of bortezomib and melphalanEric Sanchez, Mingjie Li, Jeffrey A Steinberg, et al.
The Journal of Surgical Research|July 3, 2007
Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: roles of Fas, Apaf-1, NFkappaB, IAPs, Smac/DIABLO, and AIFSergio Huerta, John H Heinzerling, Yu-Mei Anguiano-Hernandez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2007
Expression of X-linked inhibitor of apoptosis protein is a strong predictor of human prostate cancer recurrenceDavid B Seligson, Fumiya Hongo, Sara Huerta-Yepez, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2004
Chemokine monokine induced by IFN-gamma/CXC chemokine ligand 9 stimulates T lymphocyte proliferation and effector cytokine productionDavid Whiting, George Hsieh, James J Yun, et al.
International Journal of Oncology|June 9, 2005
Expression of transcription factor Yin Yang 1 in prostate cancerDavid Seligson, Steve Horvath, Sara Huerta-Yepez, et al.
Blood|June 29, 2006
Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptorPatrick P Ng, Gustavo Helguera, Tracy R Daniels, et al.
Pageof 20

Showing results (161-170 of 192) with videos related to

Sort By:
Pageof 20
Cancer Investigation|February 25, 2009
YY1 Over-expression in human brain gliomas and meningiomas correlates with TGF-beta1, IGF-1 and FGF-2 mRNA levelsStavroula Baritaki, Anthoula M Chatzinikola, Antonios F Vakis, et al.
Cell Cycle (Georgetown, Tex.)|August 9, 2011
Mcl-1 and YY1 inhibition and induction of DR5 by the BH3-mimetic Obatoclax (GX15-070) contribute in the sensitization of B-NHL cells to TRAIL apoptosisMelisa A Martínez-Paniagua, Stavroula Baritaki, Sara Huerta-Yepez, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 10, 2011
An antibody-based multifaceted approach targeting the human transferrin receptor for the treatment of B-cell malignanciesTracy R Daniels, Elizabeth Ortiz-Sánchez, Rosendo Luria-Pérez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2004
Downregulation of Smac/DIABLO expression in renal cell carcinoma and its prognostic significanceYoichi Mizutani, Hiroyuki Nakanishi, Kosuke Yamamoto, et al.
British Journal of Haematology|December 5, 2009
The proteasome inhibitor CEP-18770 enhances the anti-myeloma activity of bortezomib and melphalanEric Sanchez, Mingjie Li, Jeffrey A Steinberg, et al.
The Journal of Surgical Research|July 3, 2007
Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: roles of Fas, Apaf-1, NFkappaB, IAPs, Smac/DIABLO, and AIFSergio Huerta, John H Heinzerling, Yu-Mei Anguiano-Hernandez, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2007
Expression of X-linked inhibitor of apoptosis protein is a strong predictor of human prostate cancer recurrenceDavid B Seligson, Fumiya Hongo, Sara Huerta-Yepez, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 10, 2004
Chemokine monokine induced by IFN-gamma/CXC chemokine ligand 9 stimulates T lymphocyte proliferation and effector cytokine productionDavid Whiting, George Hsieh, James J Yun, et al.
International Journal of Oncology|June 9, 2005
Expression of transcription factor Yin Yang 1 in prostate cancerDavid Seligson, Steve Horvath, Sara Huerta-Yepez, et al.
Blood|June 29, 2006
Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptorPatrick P Ng, Gustavo Helguera, Tracy R Daniels, et al.
Pageof 20